{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023794","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.893028+00:00","generated_at":"2026-06-11T09:07:17.856812+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BIO-key Q2 revenue flat at $1.9M; net loss narrows to $1.4M","bullets":["Q2 revenue $1.9M flat YoY; first-half revenue up 29% to $5.9M.","Q2 gross margin improved to 69% from 63%; gross profit $1.3M up 8%.","Q2 net loss narrowed to $1.4M from $1.7M; operating expenses down 10%.","Signed $0.3M defense ministry order in early Q3; expanding EMEA partnerships.","Management confident in FY2023 top-line growth and bottom-line improvements."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023794","json":"https://secwatch.observer/filing/0001437749-23-023794.json","markdown":"https://secwatch.observer/filing/0001437749-23-023794.md","text":"https://secwatch.observer/filing/0001437749-23-023794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/0001437749-23-023794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/bkyi20230814_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:07:17.856812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3477c4d3ce6dce9dcbbc8179713395296ec9e0d5","claim":"BIO KEY INTERNATIONAL INC reported second quarter ended June 30, 2023 results: revenue $1.9M, net income $1.4M.","evidence_excerpt":"filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_560801.htm EXHIBIT 99.1 ex_560801.htm Exhibit 99.1 Identity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M; Hosts Investor Call Tomorrow, August 15 th at 10am ET WALL, NJ – August 14, 2023 - BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923023794/0001437749-23-023794-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$1.9M"},{"label":"Net income","value":"$1.4M"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}